Trial · NCT02290431
Results by group51
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 51
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Near Complete Response (nCR)/ Complete Response (CR) Rate | LBH589 + Bortezomib + Dexamethasone | 48.4 | 90% Confidence Interval 33.6 to 63.2 | Percentage of participants | |
| Progression Free Survival (PFS) | LBH589 + Bortezomib + Dexamethasone | 15.3 | 95% Confidence Interval 10.4 to 31.4 | months | |
| Overall Response Rate (ORR) | LBH589 + Bortezomib + Dexamethasone | 80.6 | 95% Confidence Interval 62.5 to 92.5 | Percentage of participants | |
| Overall Survival (OS) | LBH589 + Bortezomib + Dexamethasone | NA | 95% Confidence Interval NA to NA | months | |
| Minimal Response Rate (MRR) Per Investigator | LBH589 + Bortezomib + Dexamethasone | 9.7 | Percentage of participants | ||
| Time to Response (TTR) Per Investigator | LBH589 + Bortezomib + Dexamethasone | 1.4 | 95% Confidence Interval 0.7 to 2.1 | months | |
| Time to Progression/Relapse (TTP) Per Investigator | LBH589 + Bortezomib + Dexamethasone | 15.3 | 95% Confidence Interval 10.4 to 31.4 | months | |
| Duration of Response (DOR) Per Investigator | LBH589 + Bortezomib + Dexamethasone | 22.7 | 95% Confidence Interval 9.7 to 30.5 | months | |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Baseline | 112.33 | Full Range 80.7 to 144.5 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 12 | 91.75 | Full Range 65.7 to 147.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 24 | 100.33 | Full Range 59.2 to 149.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 36 | 125.83 | Full Range 91.0 to 149.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 48 | 114.25 | Full Range 101.7 to 145.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 60 | 109.92 | Full Range 82.5 to 137.3 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 72 | 108.00 | Full Range 108.0 to 108.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 84 | 101.00 | Full Range 92.0 to 110.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 96 | 121.67 | Full Range 86.5 to 133.0 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 108 | 120.17 | Full Range 117.0 to 123.3 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 120 | 125.25 | Full Range 124.7 to 125.8 | scores on a scale |
| Quality of Life (QoL) as Measured by FACT/GOG-Ntx Total Score | LBH589 + Bortezomib + Dexamethasone | Week 132 | 114.00 | Full Range 109.3 to 118.7 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02290431/results